» Articles » PMID: 34131047

Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study

Abstract

Objective: To determine whether β-cell hyperresponsiveness and insulin resistance in youth versus adults in the Restoring Insulin Secretion (RISE) Study are related to increased glucagon release.

Research Design And Methods: In 66 youth and 350 adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes (drug naive), we performed hyperglycemic clamps and oral glucose tolerance tests (OGTTs). From clamps we quantified insulin sensitivity (M/I), plasma fasting glucagon and C-peptide, steady-state glucagon and C-peptide at glucose of 11.1 mmol/L, and arginine-stimulated glucagon (acute glucagon response [AGR]) and C-peptide (ACPRmax) responses at glucose >25 mmol/L.

Results: Mean ± SD fasting glucagon (7.63 ± 3.47 vs. 8.55 ± 4.47 pmol/L; = 0.063) and steady-state glucagon (2.24 ± 1.46 vs. 2.49 ± 1.96 pmol/L, = 0.234) were not different in youth and adults, respectively, while AGR was lower in youth (14.1 ± 5.2 vs. 16.8 ± 8.8 pmol/L, = 0.001). Significant age-group differences in insulin sensitivity, fasting C-peptide, steady-state C-peptide, and ACPRmax were not related to glucagon. Fasting glucose and glucagon were positively correlated in adults ( = 0.133, = 0.012) and negatively correlated in youth ( = -0.143, = 0.251). In both age-groups, higher fasting glucagon was associated with higher fasting C-peptide (youth = 0.209, = 0.091; adults = 0.335, < 0.001) and lower insulin sensitivity (youth = -0.228, = 0.066; adults = -0.324, < 0.001). With comparable fasting glucagon, youth had greater C-peptide and lower insulin sensitivity. OGTT suppression of glucagon was greater in youth.

Conclusions: Youth with IGT or recently diagnosed type 2 diabetes (drug naive) have hyperresponsive β-cells and lower insulin sensitivity, but their glucagon concentrations are not increased compared with those in adults. Thus, α-cell dysfunction does not appear to explain the difference in β-cell function and insulin sensitivity in youth versus adults.

Citing Articles

Glycemia, Insulin Sensitivity, and Secretion Improve 3 Months Post-sleeve Gastrectomy in Youth With Type 2 Diabetes.

Dobbs T, Cree M, Bailey A, Baumgartner A, Garrish J, Diniz-Behn C J Endocr Soc. 2025; 9(3):bvaf020.

PMID: 39911520 PMC: 11795195. DOI: 10.1210/jendso/bvaf020.


Glucagon, Metabolic Dysfunction-Associated Steatotic Liver Disease and Amino Acids in Humans and Animals without Diabetes Mellitus-An Evidence Map.

Maruszczak K, Koren P, Radzikowski K, Pixner T, Suppli M, Wewer Albrechtsen N Life (Basel). 2024; 14(10).

PMID: 39459592 PMC: 11509797. DOI: 10.3390/life14101292.


Proteomic Analysis Uncovers Multiprotein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus.

Pyle L, Choi Y, Narongkiatikhun P, Sharma K, Waikar S, Layton A Clin J Am Soc Nephrol. 2024; 19(12):1603-1612.

PMID: 39432369 PMC: 11637700. DOI: 10.2215/CJN.0000000000000559.


Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

Pixner T, Chaikouskaya T, Lauth W, Zimmermann G, Morwald K, Lischka J Front Endocrinol (Lausanne). 2024; 15:1368570.

PMID: 39027470 PMC: 11254805. DOI: 10.3389/fendo.2024.1368570.


Challenges and pitfalls of youth-onset type 2 diabetes.

Sabolic L, Marusic S, Cigrovski Berkovic M World J Diabetes. 2024; 15(5):876-885.

PMID: 38766423 PMC: 11099376. DOI: 10.4239/wjd.v15.i5.876.


References
1.
Maruyama H, HISATOMI A, Orci L, GRODSKY G, Unger R . Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984; 74(6):2296-9. PMC: 425424. DOI: 10.1172/JCI111658. View

2.
Ward W, Best J, Halter J, Porte Jr D . Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man. J Clin Endocrinol Metab. 1984; 58(3):449-53. DOI: 10.1210/jcem-58-3-449. View

3.
Manell H, Staaf J, Manukyan L, Kristinsson H, Cen J, Stenlid R . Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2016; 101(3):1181-9. DOI: 10.1210/jc.2015-3885. View

4.
Rorsman P, Berggren P, Bokvist K, Ericson H, Mohler H, Ostenson C . Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature. 1989; 341(6239):233-6. DOI: 10.1038/341233a0. View

5.
Rizza R, Mandarino L, Gerich J . Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981; 240(6):E630-9. DOI: 10.1152/ajpendo.1981.240.6.E630. View